Journal of Developing Drugs

Journal of Developing Drugs
Open Access

ISSN: 2329-6631

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Editorial Board

Yavuz S Silay
Editor-in-Chief
Director, Therapeutic Medical Head, Teva Neurosciences Commercial Organization
USA

Walter J Lukiw
Executive Editor
Associate Professor, Department of Ophthalmology
Louisiana State University, USA

Ritu Aneja
Executive Editor
Associate Professor, Department of Biology
Georgia State University, USA

Submit Manuscript

Submit manuscript at www.editorialmanager.com/pharma/ or send as an e-mail attachment to the Editorial Office at [email protected]

About the Journal

Impact Factor: 0.67;  NLM ID: 101646699; Index Copernicus Value: 62.16 

Journal of Developing Drugs is at higher echelons that enhance the intelligence and information dissemination on topics closely related to Developing Drugs.The Journal provides a unique forum dedicated to scientists to express their research articles, review articles, case reports and short communications on an array of Journal of Developing Drugs Research.

The Developing Drugs Peer Reviewed Journals are proficiently supported by universally prominent Editorial Board members. Developing Drugs journal Impact factor is mainly calculated based on the number of articles that undergo a double blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles. Abstracts and full texts of all articles published by Developing Drugs Open Access Journals are freely accessible to everyone immediately after publication.

Journal of Developing Drugs under Open Access platform focuses on pharmaceuticals coming up through the pipeline and thus aims to advance our understanding of the action of drugs, their harmful effects, prevention and treatment of both existing as well as emerging diseases.

The journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing. Journal of Developing Drugs is one of the best Open Access journals of Scholarly publication.

This Pharmaceutical Science Journal adapts to Editorial Manager System for quality in review process. The review process is performed by the editorial board members of Journal of Developing Drugs or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

Authors can submit their manuscripts through online link https://www.scholarscentral.org/submission/developing-drugs.html or send as an e-mail attachment to the Editorial office  [email protected] .

Journal Highlights

Top